Quarterly Call Option Transactions in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during . The information is specifically focused on institutions that hold call options of Protagonist Therapeutics, Inc.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 398,800 | 639,500 | 1,038,300 | — | 1,038,300 | |||
| Q4 2021 | 84,400 | 352,220 | 436,620 | 403,800 | 0 | 403,800 | 32,820 | |
| Q1 2022 | 689,000 | 5,000 | 694,000 | 244,800 | 285,600 | 530,400 | 163,600 | |
| Q2 2022 | 460,500 | 306,800 | 767,300 | 147,300 | 160,800 | 308,100 | 459,200 | |
| Q3 2022 | 69,200 | 0 | 69,200 | 204,500 | 0 | 204,500 | -135,300 | |
| Q4 2022 | 142,300 | 0 | 142,300 | 10,300 | 0 | 10,300 | 132,000 | |
| Q1 2023 | 321,200 | 477,300 | 798,500 | — | 798,500 | |||
| Q2 2023 | 267,400 | 84,500 | 351,900 | 290,300 | 0 | 290,300 | 61,600 | |
| Q3 2023 | — | 214,500 | 0 | 214,500 | -214,500 | |||
| Q4 2023 | 11,100 | 0 | 11,100 | 8,200 | 0 | 8,200 | 2,900 | |
| Q1 2024 | — | 495,300 | 0 | 495,300 | -495,300 | |||
| Q2 2024 | 1,800 | 6,400 | 8,200 | 21,300 | 0 | 21,300 | -13,100 | |
| Q3 2024 | 16,800 | 41,100 | 57,900 | 2,400 | 0 | 2,400 | 55,500 | |